期刊文献+

大剂量腺苷蛋氨酸治疗严重慢性肝病所致高胆红素血症的疗效观察 被引量:7

Effect of large doses of ademetionine on hyperbilirubinemia caused by severe chronic liver disease
暂未订购
导出
摘要 目的观察大剂量腺苷蛋氨酸对各种原因导致的高胆红素血症的疗效。方法严重慢性肝病患者63例(病毒性肝炎所致肝硬化39例,酒精性肝硬化18例,药物性肝病2例,原发性胆汁性肝硬化4例)。入院时平均血清胆红素水平为195.1 mmol/L,经常规保肝治疗4周后,肝功能无明显改善,胆红素水平升高。在原治疗基础上,加大腺苷蛋氨酸剂量至2.0 g,2次/d静推。每周复查肝功能,以血清总胆红素水平作为主要观察指标。结果 63例患者中,3例乙肝和酒精混合因素的肝硬化在入组治疗不足2周时,因出现消化道大出血而退出观察。60例患者治疗满4周,胆红素水平明显下降,与常规保守治疗后胆红素水平相比,差异有统计学意义(P<0.01)。结论在某些严重肝病所导致的严重高胆红素血症患者,常规保肝治疗效果不佳时,可以尝试大剂量S-腺苷蛋氨酸治疗。 Objective To observe the effects of high dose ademetionine on hyperbilirubinemia caused by all kinds of causes. Methods 63 cases of severe chronic liver disease ( 39 cases of viral hepatitis induced liver cirrhosis, 18 cases of alcoholic cirrhosis ,2 cases of drug induced liver disease ,4 cases of primary biliary cirrhosis). At the time of admission, the mean serum bilirubin level was 195. 1 mmol/L, and the liver function had no significant improvement af- ter 4 weeks of regular treatment while the bilirubin level was improved. The dose of ademetionine increased to 2. 0 g iv. ( twice daily) with the basis of original treatment. The liver function was observed weekly with the total serum bili- rubin level as the main indicator. Results 3 cases of cirrhosis induced by hepatitis B and alcohol factors dropped out due to massive upper gastrointestinal hemorrhage for less than 2 weeks of treatment. 60 cases were treated for 4 weeks, and the total serum bilirubin level decreased, compared with regular treatment ( P 〈 0.01 ). Conclusion Large dose of ademetionine can be attempted in treatment for hyperbilirubinemia induced by some severe liver disease when the effects of conventional treatment is poor.
出处 《实用药物与临床》 CAS 2012年第9期559-560,共2页 Practical Pharmacy and Clinical Remedies
关键词 腺苷蛋氨酸 高胆红素血症 Ademetionine Hyperbilirubinemia
  • 相关文献

参考文献7

二级参考文献28

  • 1王晓东,彭冰,姚强,张力,艾瑛,邢爱耘,刘兴会,刘淑芸.妊娠肝内胆汁淤积症1210例围生结局分析[J].中华医学杂志,2006,86(7):446-449. 被引量:84
  • 2Conales F, Ochoa P,Rins C, et al. Inhibition of glutathiong synthesis in the liver leads o S - adenosyl - L - methionine synthetase reduction[ J ]. Hepatology, 1992,14 ( 3 ) : 528 - 533.
  • 3Watson WH, Zhao Y, chawla RK. S - adenosyhnethionine attenuates the lipopoly saccharide - induced expression of the gene for tumour necrosis factoralpha [ J ]. Biochem J. 1999,342 ( 1 ) : 21 - 25.
  • 4Manzillo G, piccinino F, Surrenti C, et al. Muhicentre double - blind placebo - controlled study of intravenous and oral S - adenosy - L - methionioe(SAMe) in cholestatic patients with liver disease [ J ]. Drug Invest, 1992,4 ( suppl4 ) : 90 - 100.
  • 5赵龙风.肝病的现代诊断与治疗[M].北京:中国医药科技出版社,2001:409.
  • 6Mato JM,Camara J,Caballena L,et al.S-adenosylmeth ion ine in alcoholic liver cirrhosis.A random ized,placebo-controlled,double-blind,multicenter clinical trial[J].Hepatol,1999,30(6):1081-1089.
  • 7Purohit V,Russo D.Role of S-adenosyl-L-methionine in the treatment of alcoholic liver disease,introduction and summary of the symposium[J].Alcohol,2002,27(3):151-154.
  • 8Matsui H, Kawada N. Effect of S-adenesyl-L-methionine on the activation, proliferation and contraction of hepatic stellate cells [J]. Eur J Pharmacology, 2005, 509( 1 ): 31-36.
  • 9Mato JM, Camara J, Fernandez J, et al. S-adenesyl-L-methionine in alcoholic liver cirrhosi: a randomized, placebo-controlled, double-blind, multicenter clinical trial [ J ]. J Hepatol, 1999, 30 (6) : 1081-1089.
  • 10Alpert JE, Papkostas G, Mischoulon D, et al. S-adenosyl-L-methio- nine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine [J]. J Clin Psychopharmacology, 2004, 24(6) : 661-664.

共引文献42

同被引文献61

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部